IRMD - Iradimed Co - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IRMD is currently covered by 1 analysts

Iradimed Co's activity chart (see below) currently has 10 price targets and 7 ratings on display. The stock rating distribution of IRMD is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 316.8 days.

Highest price target for IRMD is $83, Lowest price target is $83.

Most recent stock forecast was given by from LAKE STREET on 03-Nov-2025. First documented stock forecast 31-Oct-2017.

Best performing analysts who are covering IRMD - Iradimed Co:

Jason Wittes Frank Takkinen Scott Henry

Currently out of the existing stock ratings of IRMD, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 04-Aug-2023

$60

8 months 7 days ago
(03-Nov-2025)

3/3 (100%)

$17.97 (42.76%)

430

Buy Since 22-Apr-2024

$72

$-21.96 (-23.37%)

$60

1 years 4 months 26 days ago
(14-Feb-2025)

3/3 (100%)

$17.74 (32.69%)

277

Buy Since 31-Oct-2017

$48

$-45.4 (-48.61%)

$42

3 years 5 months 4 days ago
(05-Feb-2023)

7/7 (100%)

$10.84 (29.17%)

170

Show more analysts

Please expand the browser size to see the chart

What is IRMD (Iradimed Co) average time for price targets to be met?

On average it took 316.8 days on average for the stock forecasts to be realized with a an average price target met ratio 100

Which analyst has the current highest performing score on IRMD (Iradimed Co) with a proven track record?

JASON WITTES

Which analyst has the current lower performing score on IRMD (Iradimed Co) with a proven track record?

SCOTT HENRY

Which analyst has the most public recommendations on IRMD (Iradimed Co)?

Jason Wittes has 10 price targets and 13 ratings on IRMD

Which analyst is the currently most bullish on IRMD (Iradimed Co)?

Frank Takkinen with highest potential upside - $0

Which analyst is the currently most reserved on IRMD (Iradimed Co)?

Scott Henry with lowest potential downside - -$45.4

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?